The Role of Heme Oxygenase-1 in Lung Cancer Cells.
10.4046/trd.2006.60.3.304
- Author:
Jong Hoon JUNG
1
;
Hak Ryul KIM
;
Eun Jung KIM
;
Ki Eun HWANG
;
So Young KIM
;
Jung Hyun PARK
;
Hwi Jung KIM
;
Sei Hoon YANG
;
Eun Taik JEONG
Author Information
1. Department of Internal Medicine, College of Medicine Wonkwang University, Iksan, Korea. kshryj@wonkwang.ac.kr
- Publication Type:Original Article
- Keywords:
Heme oxygenase-1;
Lung cancer
- MeSH:
Bilirubin;
Biliverdine;
Blotting, Western;
Carbon Monoxide;
Cell Line;
Cytoprotection;
Heme Oxygenase-1*;
Heme*;
Humans;
Hydrogen Peroxide;
Iron;
Lung Neoplasms*;
Lung*;
Peroxidase;
Raphanus;
RNA;
RNA, Small Interfering
- From:Tuberculosis and Respiratory Diseases
2006;60(3):304-313
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Heme oxygenase-1 (HO-1) is an inducible enzyme that catalyzes the oxidative degradation of heme to form biliverdin, carbon monoxide (CO), and free iron. The current evidence has indicated a critical role of HO-1 in cytoprotection and also in other, more diverse biological functions. It is known that the high expression of HO-1 occurs in various tumors, and that HO-1 has an important role in rapid tumor growth because of its antioxidative and antiapoptotic effects. Therefore, the role of HO-1 was analyzed in human lung cancer cell lines, and especially in the A549 cell line. MATERIAL AND METHODS: Human lung cancer cell lines, i.e., A549, NCI-H23, NCI-H157 and NCI-H460, were used for this study. The expression of HO-1 in the untreated state was defined by Western blotting. ZnPP, which is the specific HO inhibitor we used, and the viability of cells were tested for by conducting MTT assaysy. The HO enzymatic activity, as determined via the bilirubin level, was also indirectly measured. Moreover, the generation of intracellular hydrogen peroxide (H2O2) was monitored fluorimetrically with using a scopoletin-horse radish peroxidase (HRP) assay and 2',7'-dichlorofluorescein diacetate (DCFH-DA). We have also transfected small HO-1 interfering RNA (siRNA) into A549 cells, and the apoptotic effects were evaluated by flow cytometric analysis and Western blotting. RESULTS: The A549 cells had a greater expression of HO-1 than the other cell lines, whereas ZnPP significantly decreased the viability of the A549 cells more than the viability of the other lung cancer cells in a dose-dependant fashion. Consistent with the viability, the HO enzymatic activity also was decreased. Moreover, intracellular H2O2 generation via ZnPP was induced in a dose-dependent manner. Apoptotic events were, then induced in the HO-1 siRNA transfected A549 cells. CONCLUSION: HO-1 provides new important insights into the possible molecular mechanism of the antitumor therapy in lung cancer.
